• Board of Directors

    • Thomas Staab, BioCryst Pharmaceuticals, Board Chairman
    • Jeff Abbey, Argos Therapeutics
    • Peyton Anderson, Affinergy
    • Lynn Bottone, Pfizer
    • Dennis Burns, TCG Group
    • Christopher Capel, Smith Anderson
    • Jeff Collins, Pappas Ventures
    • Terry Costello Royal Hill Consulting
    • Jay Dixon, PPD
    • Mike Elder, Novozymes
    • Tom Fagley, Hughes Pittman Gupton
    • Ed Field, Biorestorative
    • Neal Fowler, Liquidia Technologies
    • Amy Fullbright, K&L Gates
    • Shawn Gallagher, Eisai
    • Maeve Gardner, GSK
    • Noel Harvey, BD Technologies
    • Christof Jensen, UCB
    • Matt Keffer, PricewaterhouseCoopers
    • Robert Kenyon, Biogen
    • Scott Kohne, Bayer
    • William Lee, Cato Bioventures
    • Susan Lillard Thomason, Quintiles Transnational Corp.
    • Greg O’Donnell, CapStrat
    • Russ Read, National Center for Biotechnology Workforce
    • Scott Sewell, Cook Medical
    • Oliver Sherrill, Alexandria Real Estate Equities
    • Giles Shih, BioResource International
    • Gary Shope, Patheon
    • Mark Velleca, G1 Therapeutics
    • Brad Walters, RTI International
    • Eric Ward, AgBiome
    • Mark Weedon
    • Tim Willis, MED1 Ventures 

  • Mark Your Calendar

     
  • Latest Tweets